Evidence map›Paper›PMID 38644103›Full record

ArticleTrends in cancer2024

Precise timing of audiovisual stimulation conquers chemobrain.

Lindsey C Mehl, Erin M Gibson

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Trends in cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 90% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Lindsey C MehlCancer Biology Graduate Program, Stanford University School of Medicine, Palo Alto, CA 94305, USA.
Erin M GibsonDepartment of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto, CA 94305, USA. Electronic address: egibson1@stanford.edu.
Stanford Medicine · USStanford University · US

Funding

Leveraging innovative technologies in basic and clinical cancer researchT32CA009302 · NCI · STANFORD UNIVERSITY · PI LAURA D ATTARDI, Aaron M Newman · 1985 to 2026
$19.1M
Circadian mechanisms of myelinationR01NS126610 · NINDS · STANFORD UNIVERSITY · PI Erin G Valdez · 2023 to 2026
$1.9M
Circadian regulation of cancer therapy-associated neuroinflammationR21CA267135 · NCI · STANFORD UNIVERSITY · PI VALDEZ, ERIN G · 2022 to 2023
$417k
NCI NIH HHS R21 CA267135NCI NIH HHS T32 CA009302NINDS NIH HHS R01 NS126610
6 · The paper itself

Abstract

In a recent study, Kim et al. utilized gamma entrainment using sensory stimuli (GENUS) to rescue cognitive impairment and glial dysregulation associated with cisplatin and methotrexate chemotherapy, specifically when applied both throughout and after chemotherapy administration. GENUS provides a time-dependent, non-invasive method for treating chemobrain, with broader implications for resolving neurodegenerative neuroinflammation.

Indexed as

CisplatinAcoustic StimulationAnimalsAntineoplastic AgentsCognitive DysfunctionHumansMethotrexatePhotic StimulationTime FactorsAntineoplastic AgentsCisplatinMethotrexateaudiovisual stimulationchemobrainchemotherapycognitive impairmentGENUSneuroinflammation

Identifiers

PMID38644103
PMCPMC11096014
OpenAlexW4394987603

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.